Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gottesman

Showing results (411-420 of 602) with videos related to

Pageof 61
Sort By:
Japanese Journal of Cancer Research : Gann|November 1, 1989
Detection of multidrug resistance (MDR1) gene RNA expression in human tumors by a sensitive ribonuclease protection assayK Ueda, Y Yamano, N Kioka, et al.
Biochemistry|September 30, 1998
Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transportC A Hrycyna, L E Airan, U A Germann, et al.
Molecular Pharmacology|October 1, 1991
Fluorescent verapamil derivative for monitoring activity of the multidrug transporterI H Lelong, A P Guzikowski, R P Haugland, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 1, 1989
The multidrug transporter: rapid modulation of efflux activity monitored in single cells by the morphologic effects of vinblastine and daunomycinP L Konen, S J Currier, A V Rutherford, et al.
The Journal of Biological Chemistry|December 24, 2002
Studies with novel Pdr5p substrates demonstrate a strong size dependence for xenobiotic effluxJohn Golin, Suresh V Ambudkar, Michael M Gottesman, et al.
Journal of Inorganic Biochemistry|May 30, 2015
Reduced accumulation of platinum drugs is not observed in drug-resistant ovarian cancer cell lines derived from cisplatin-treated patientsMarina Stukova, Matthew D Hall, Samantha D Tsotsoros, et al.
The Journal of Biological Chemistry|December 15, 1992
Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transportersS J Currier, S E Kane, M C Willingham, et al.
The Journal of Biological Chemistry|November 15, 1985
Characterization of a cyclic AMP-resistant Chinese hamster ovary cell mutant containing both wild-type and mutant species of type I regulatory subunit of cyclic AMP-dependent protein kinaseT J Singh, J Hochman, R Verna, et al.
Journal of Molecular Biology|August 30, 2008
Synonymous mutations and ribosome stalling can lead to altered folding pathways and distinct minimaChung-Jung Tsai, Zuben E Sauna, Chava Kimchi-Sarfaty, et al.
Molecular Cancer Therapeutics|December 20, 2007
Evidence for dual mode of action of a thiosemicarbazone, NSC73306: a potent substrate of the multidrug resistance linked ABCG2 transporterChung-Pu Wu, Suneet Shukla, Anna Maria Calcagno, et al.
Pageof 61

Showing results (411-420 of 602) with videos related to

Sort By:
Pageof 61
Japanese Journal of Cancer Research : Gann|November 1, 1989
Detection of multidrug resistance (MDR1) gene RNA expression in human tumors by a sensitive ribonuclease protection assayK Ueda, Y Yamano, N Kioka, et al.
Biochemistry|September 30, 1998
Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transportC A Hrycyna, L E Airan, U A Germann, et al.
Molecular Pharmacology|October 1, 1991
Fluorescent verapamil derivative for monitoring activity of the multidrug transporterI H Lelong, A P Guzikowski, R P Haugland, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|July 1, 1989
The multidrug transporter: rapid modulation of efflux activity monitored in single cells by the morphologic effects of vinblastine and daunomycinP L Konen, S J Currier, A V Rutherford, et al.
The Journal of Biological Chemistry|December 24, 2002
Studies with novel Pdr5p substrates demonstrate a strong size dependence for xenobiotic effluxJohn Golin, Suresh V Ambudkar, Michael M Gottesman, et al.
Journal of Inorganic Biochemistry|May 30, 2015
Reduced accumulation of platinum drugs is not observed in drug-resistant ovarian cancer cell lines derived from cisplatin-treated patientsMarina Stukova, Matthew D Hall, Samantha D Tsotsoros, et al.
The Journal of Biological Chemistry|December 15, 1992
Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transportersS J Currier, S E Kane, M C Willingham, et al.
The Journal of Biological Chemistry|November 15, 1985
Characterization of a cyclic AMP-resistant Chinese hamster ovary cell mutant containing both wild-type and mutant species of type I regulatory subunit of cyclic AMP-dependent protein kinaseT J Singh, J Hochman, R Verna, et al.
Journal of Molecular Biology|August 30, 2008
Synonymous mutations and ribosome stalling can lead to altered folding pathways and distinct minimaChung-Jung Tsai, Zuben E Sauna, Chava Kimchi-Sarfaty, et al.
Molecular Cancer Therapeutics|December 20, 2007
Evidence for dual mode of action of a thiosemicarbazone, NSC73306: a potent substrate of the multidrug resistance linked ABCG2 transporterChung-Pu Wu, Suneet Shukla, Anna Maria Calcagno, et al.
Pageof 61